Jia Jie Biomedical Co., Ltd. (4109.TWO)

TWD 21.85

(0.0%)

Market Cap (In TWD)

2.15 Billion

Revenue (In TWD)

332.75 Million

Net Income (In TWD)

144.14 Million

Avg. Volume

4.56 Million

Currency
TWD
Country
Consumer Defensive
Open
-
Prev. Close
-
Day Range
-
Year Range
16.35-39.6
PE
-
EPS
-
Beta Value
0.528
ISIN
TW0004109004
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Consumer Defensive
Industry
Packaged Foods
CEO
Wen-Fang Hsieh
Employee Count
-
Website
https://www.jiajiebio.com
Ipo Date
2007-12-31
Details
Jia Jie Biomedical Co., Ltd. produces and sells health foods in Taiwan and Mainland China. The company engages in the processing, sale, and trading of softshell turtle food; manufacture of dairy products; miscellaneous food manufacturing, such as softshell turtle egg powder capsules, enzyme powder, tortoise jelly, softshell turtle oil, and powder capsules; and import and export, distribution, bidding, quotation of the products. It is also involved in the wholesale of nonalcoholic beverages, candy, baked food, supplementary food, groceries, daily commodities, and cosmetics; production of water purification equipment and related parts; life and property insurance brokerage business; development and production of aquatic product technology; and development of biological products. The company was formerly known as Murad Chia Jei Biotechnology Co., Ltd. and changed its name to Jia Jie Biomedical Co., Ltd. in June 2019. Jia Jie Biomedical Co., Ltd. was founded in 1995 and is based in Kaohsiung, Taiwan.